Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06949774

INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)

INcentives and ReMINDers to Improve Long-term Medication Adherence

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
550 (estimated)
Sponsor
RAND · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Low medication adherence when initiating antiretroviral treatment (ART) is a key barrier to HIV virologic suppression, resulting in avoidable cases of drug resistance, death, and viral transmission. Routinized pill-taking can lead to successful long-term ART adherence, and short-term behavioral economics-based supports are a novel way to overcome the limited success of existing routinization interventions. This study proposes to test this combined approach for promoting long-term ART adherence using a Stage III Sequential, Multiple Assignment, Randomized Trial (SMART) design in one of the largest HIV clinics in Uganda to identify the most cost-effective adaptive intervention that if found effective is generalizable to other settings and other chronic diseases.

Detailed description

Building on a previous R34 study, the investigators will adapt and deliver the INMIND approach to 550 ART initiators at Mildmay. Participants will initially be randomized to receive either usual care (Control, n=275) or daily text messages (Messages, n=275) to support adherence routines. At months 1 and 2, participants may revise their adherence plans. Those showing \<80% adherence in month 3 will be re-randomized to receive either monthly or monthly escalated prize incentives for the next three months. Adherence will be monitored for an additional 12 months (total follow-up: 18 months) to assess long-term routine maintenance and recovery after interruptions. The SMART design will help identify the most cost-effective intervention sequencing. A cost-effectiveness analysis and stakeholder dissemination will support future scale-up. The investigators hypothesize that Messages will be more effective than Control as a first-stage treatment; that monthly escalated prizes will be more effective than monthly prizes as a second-stage treatment; and that the mechanisms of lack of Salience and Present Bias will mediate the effect of INMIND on our primary and secondary outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDaily Text MessagesParticipants will receive daily text message reminders to use their routine behavior to trigger medication adherence.
BEHAVIORALIncentivization based on timely ART adherenceParticipants will be eligible to (draw a prize in monthly prize group) or get a monthly prize (monthly escalated group) if they take their medication within +/-one hour of the stated existing routine to which pill-taking is anchored on at least 80% of days for 3-months.

Timeline

Start date
2025-04-02
Primary completion
2028-12-31
Completion
2029-10-31
First posted
2025-04-29
Last updated
2025-09-11

Locations

1 site across 1 country: Uganda

Source: ClinicalTrials.gov record NCT06949774. Inclusion in this directory is not an endorsement.